GlassScriptPhysician profile
Collin Kraus
NPI 1437439809
$1,787.63
in general payments reported to CMS, 2019-2025
9 companies · $17.51 in 2025
The $17.51 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $32.26 · 2021: $438 · 2022: $520 · 2023: $411 · 2024: $231 · 2025: $17.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $536.60 | 2020-2023 | Miniendo II, Spark |
| Gc America INC. | $391.68 | 2021-2023 | Bio-Active, Mipaste One |
| 3m Company | $280.31 | 2019-2022 | |
| Envista Holdings Corporation | $248.32 | 2024-2025 | Spark, Titanium Orthos, Mini-Tip Kit |
| Nobel Biocare USA | $127.26 | 2023 | Nobelactive |
| Align Technology, INC. | $95.10 | 2021 | |
| Forestadent USA, INC. | $64.66 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $29.76 | 2019 | |
| Dentsply Sirona INC | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.